Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 42, Issue 4, Pages 441-451
Publisher
Wiley
Online
2015-06-24
DOI
10.1111/apt.13294
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Old-age inflammatory bowel disease onset: A different problem?
- (2016) Joaquin Hinojosa del Val WORLD JOURNAL OF GASTROENTEROLOGY
- 642 “Infectious Complications in IBD Patients on Immunomodulators, Corticosteroids, and Anti-TNF Therapy: Is Elderly Age a Predictor of Higher Complication Rates?”
- (2015) Christina Tofani et al. GASTROENTEROLOGY
- Aging and immunity – Impact of behavioral intervention
- (2013) Ludmila Müller et al. BRAIN BEHAVIOR AND IMMUNITY
- Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study
- (2013) Cloé Charpentier et al. GUT
- Clinical implications of ageing for the management of IBD
- (2013) Christina Y. Ha et al. Nature Reviews Gastroenterology & Hepatology
- Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry
- (2012) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease
- (2012) Shomron Ben–Horin et al. Clinical Gastroenterology and Hepatology
- Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study
- (2012) Maria Esposito et al. DERMATOLOGY
- Older Age Is Associated with Higher Rate of Discontinuation of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease
- (2012) Amit Desai et al. INFLAMMATORY BOWEL DISEASES
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
- (2012) Axel Dignass et al. Journal of Crohns & Colitis
- A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease
- (2012) Makoto Naganuma et al. JOURNAL OF GASTROENTEROLOGY
- Inflammatory Bowel Disease of the Elderly: Frequently Asked Questions (FAQs)
- (2011) Seymour Katz et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Epidemiology and Natural History of Inflammatory Bowel Diseases
- (2011) Jacques Cosnes et al. GASTROENTEROLOGY
- Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease
- (2010) Mario Cottone et al. Clinical Gastroenterology and Hepatology
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
- (2010) Gert Van Assche et al. Journal of Crohns & Colitis
- IBD in the elderly population: Results from a population-based study in Western Hungary, 1977–2008
- (2010) Peter Laszlo Lakatos et al. Journal of Crohns & Colitis
- Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials
- (2009) G. R. LICHTENSTEIN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2009) Laurent Beaugerie et al. LANCET
- Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
- (2008) H Fidder et al. GUT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started